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Abstract. The development of breast cancer involves many processes, including 
angiogenesis and metastasis. Some factors play a major role in angiogenesis, 
such as HIF-1α, and in metastasis, such as FAK and Wnt2. The aim of this study 
was to observe the effect of propolis and mangostin on the development of 
mammary gland cancer and on the expression of Wnt2 and FAK in Balb/C mice. 
Mammary gland tumors were induced in Balb/C mice by DMBA. The mice were 
divided into 5 treatment groups: negative control (K-); positive control treated 
with doxorubicin (14.04 mg/kg bw) (Dx); mice treated with propolis (0.32 mg/kg 
bw) (P) or mangostin (0.128 mg/kg bw) (M); and mice treated with a 
combination of propolis (0.32 mg/kg bw) and mangostin (0.128 mg/kg bw) 
(MP). Both mangostin and propolis did not affect the body weight of the mice. 
Treatment with propolis or treatment with propolis combined with mangostin 
was able to reduce tumor development activity in Balb/C mice. Moreover, the 
combination of mangostin and propolis was able to lower Wnt2, FAK and HIF-
1α expression. It can be concluded that the combination of propolis and 
mangostin has potential to inhibit cancer development through downregulation 
of Wnt2, FAK, and HIF1α expression. 
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1 Introduction 
Breast cancer is the leading cause of cancer deaths among women worldwide. 
The GLOBOCAN project of the International Agency for Research on Cancer 
(IARC) states that breast cancer incidence is highest in Indonesia. In 2008 there 
were approximately 156,500 new cases of breast cancer and 104,500 deaths due 
to breast cancer [1]. Cancer development involves many processes, including 
angiogenesis and metastasis. Angiogenesis is regulated by angiogenic 
stimulators such as HIF-1α protein, while focal adhesion kinase (FAK) and 
Wnt2 protein play an important role in metastasis. It is known that HIF1α 
contributes to the process of angiogenesis and is responsible for cell survival 
under conditions of hypoxia [2]. Wnt2 contributes to the EMT (epithelial 
mesenchymal transition) process and accumulation of beta-catenin in the 
nucleus, which acts as a transcription factor targeting genes that play a role in 
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the metastatic process, and FAK plays a role in the formation of focal adhesions 
and interacts with integrin [3,4] 
Nowadays many cancer therapies are focused on blocking signaling pathways 
that are important in the development of cancer. In this research we observed 
natural products that have potential to be used for combating cancer. They 
presumably block several proteins in signaling pathways involved in 
angiogenesis and metastasis. Propolis has antimicrobial, anti-inflammatory, and 
antitumor activity. Propolis is able to suppress cancer-induced angiogenesis 
through VEGF [5] and to inhibit migration of human umbilical vein endothelial 
cells (HUVEC) [6]. Moreover, it is able to induce apoptosis in breast cancer cell 
line MCF7 at a concentration of 47.45 mg/ml [7]. α-mangostin is a derivative of 
xanthone contained in the mangosteen fruit pericarp. Mangostin has several 
biological activities, such as inhibition of HIV-1 protease, antibacterial activity 
and stimulation of phagocytic cells, and can induce apoptosis in cancer cells 
HL60 [8]. Both of these natural products have been widely tested in vitro, but 
more testing is still needed to obtain a description that can represent the effect 
of both natural products separately or of a combination of both products in in 
vivo conditions. 
The diversity of pathways that can be activated or inhibited in the process of 
cancer development often leads to ineffectiveness of cancer therapies. 
Therefore, it is important to combine natural products that have different effects 
on cancer development. Until now, the effects of natural products such as 
propolis and mangostin against cancer development have not been observed. 
The aim of this study was to observe the effect of propolis and mangostin on 
mammary gland cancer development and on the expression of Wnt2 and FAK 
in Balb/C mice.  
2 Materials and Methods 
2.1 Tumor Induction in Mice and Treatment by Combination of 
α-Mangostin and Propolis Extracts 
Mice (Balb/C), purchased from LPPT Gadjah Mada University, Yogyakarta, 
were maintained in a 12-hour light dark cycle. The mice were provided with 
food and water ad libitum and were used at 9 weeks of age. DMBA was induced 
11 times in the mice after oral administration for 5 weeks. Treatment with 
propolis and α-mangostin was performed after the tumor reached a size of 200 
mm3 [9]. The treatment of the mice was approved by the Research Ethics 
Committee, Faculty of Medicine, Maranatha Christian University (Decree No. 
170/KEP/V/2014). 
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In this study, 25 female mice Balb/C were divided into 5 groups. The mice in 
group K- served as negative control. The mice in group M were treated with α-
mangostin (M-002, Indofine Chemical Company, Inc.) with a concentration of 
0.128 mg/kg body weight. The mice in group P were treated with propolis 
(RAHMI apitherapy) with a concentration of 0.32 mg/kg body weight. The 
mice in group MP were treated with mangostin (0.128 mg/kg bw) combined 
with propolis (0.32 mg/kg bw). The positive control group (Dx) was treated 
with doxorubicin (anti-cancer drug) at 14.04 mg/kg body weight. The α-
mangostin dose given to the mice was determined based on IC50 of mangostin 
in the MCF-7 cell line from our previous study [7], namely 1.6 mg/mL. The 
propolis dose given to the mice was determined based on IC50 of propolis in 
the KATO III cell line, i.e. a concentration of 4.09 mg/mL [10]. 
Alpha-mangostin and propolis were administered orally every day for 14 days. 
Doxorubicin was given intravenously to the Dx group once every 2 days over a 
span of 14 days. On the 15th day after treatment, the mice were necropsied 
using ether in a sealed container. The mice were then dissected and the tumors 
were collected and put into a container. The tumors were washed and cleaned 
with cold PBS three times and stored in a cryotube, sealed, labeled, and stored 
in liquid nitrogen. 
2.2 Preparation of Whole-cell Lysates and Nuclear Extracts 
Hundred (100) mg of tumor tissue was lysed with 400 μl buffer lysis solution A 
(10 mM HEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA pH 8, 0.1 mM EGTA pH 
8) and then incubated on ice for 10 minutes. Furthermore, NP-40 was added to 
the lysate, which was further vortexed for 10 seconds. The suspension was 
centrifuged for 1 minute at 13,000 rpm at 4 °C and then supernatant I 
(containing cytoplasmic protein) was collected. 
The nuclear pellet was re-suspended in nuclear extract buffer (20 mM HEPES 
pH 7.9, 400 mM NaCl, 1 mM EDTA pH 8, 1 mM EGTA pH 8, 25% glycerine). 
The nuclear suspension was incubated on ice for 15 minutes and then 
centrifuged at 13,000 rpm for 5 minutes. Supernatant II (contained soluble 
nuclear fraction) was stored at -80 °C. The protein concentration was 
determined with the Bradford protein assay.  
2.3 Western Blotting Analysis 
The proteins (50 µg protein) were electrophoresized on 10% SDS-PAGE gels 
and then transferred onto PVDF membranes using a Mini Trans-Blot. 
Nonspecific binding on the membranes was blocked with 5% (w/v) nonfat skim 
milk for 1 hour. The membranes were washed with TBST (Tris-Buffered Saline 
and Tween-20) five times for 10 minutes and incubated with an appropriate 
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dilution of specific primary antibodies in TBST overnight at 4 ºC. Anti-mouse 
HIF1α (Abcam ab463, 1:2000), mouse anti-FAK (Abcam ab40794, 1:6000), 
anti-mouse Wnt2 (Abcam ab109222, 1: 2500), and mouse Anti-Actin (Abcam 
ab1801, 1:1000) were used as primary antibodies. Subsequently, the membranes 
were washed with TBST and incubated with the appropriate secondary antibody 
(anti-mouse IgG-POD, Fab fragments/anti-rabbit IgG-POD (Roche 
11520709001, 1:5000) for 1 hour. The membranes were further washed five 
times for 10 minutes in a TBST. Specific protein detection was conducted by 
enhanced chemiluminescence. 
3 Results and Discussion 
3.1 Effect of Propolis and Mangostin on Mice Balb/C Body 
Weight 
The body weight of the mice in the control group (K-) increased throughout the 
2-week observation period, while that of the positive control mice (Dx), the 
mangostin group mice (M), the propolis group mice (P) continued to decrease 
during this period, as shown in Figure 1. Interestingly, the body weight of the 
MP (mangostin and propolis) group mice did not change much during the 
period of observation. This suggests that administration of propolis together 
with mangostin has no effect on the body weight of Balb/C mice. This indicates 
that propolis and mangostin are safe for consumption and do not cause side 
effects. 
bo
dy
 w
eig
ht 
(gr
)
 
Figure 1 Effect of mangostin and propolis on Balb/C mice body weight. 
Similar results have also been reported by Sugimoto, et al. [11], i.e. the 
administration of propolis did not affect the body weight of induced lung cancer 
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mice. These results show that the bioactive compound, artepillin C, in propolis 
has no detrimental effect.  
Our result showed that mangostin is not toxic and can be used as an alternative 
cancer treatment. Kosem, et al. [12] showed that Balb/C mice implanted with 
colon cancer in the NL17 cell line and treated with mangostin at a dosage of 
200 mg/kg did not lose weight during treatment. 
3.2 Effect of Propolis and Mangostin on Mammary Cancer 
Development in Balb/C Mice 
Our results show that administration of mangostin (0.128 mg/kg bw) as a single 
compound is unable to inhibit cancer development in vivo. However, extracts of 
propolis (0.32 mg/kg bw) were able to decelerate cancer progression in Balb/C 
mice, mostly when propolis was administered together with mangostin (MP 
group). The development of cancer in the MP group was retarded more than in 
the Balb/C mice treated only with propolis, as shown in Figure 2. This tendency 
shows that there are probably some interactions between both natural 
ingredients that inhibit tumor progression. 
 
Figure 2 Effect of mangostin and propolis on Balb/C mice tumor development. 
The low effect of single-compound treatment with mangostin or propolis on 
tumor development in Balb/C mice is assumed to be affected by the low dose of 
the mangostin (0.128 mg/kg bw) as well as propolis (0.32 mg/kg bw). Mouse, et 
al. (2012) have shown that the administration of propolis at a dosage of 2.5 mg 
per mouse can reduced tumor volume significantly. Additionally, Shibata, et al. 
[13] have shown a significant inhibition of tumor growth in female Balb/C mice 
that were implanted with BJMC3879luc2 cells and treated with mangostin 20 
mg/kg bw.  
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The inhibitory effect of mangostin combined with propolis on tumor 
progression is allegedly caused by the ability of mangostin and propolis to 
reduce free radicals. Free radicals, which are produced abundantly in cancer 
tissue, can be reduced by mangostin and propolis. Sun, et al. [14] and 
Padmavathi, et al. [15] have shown that mangostin and propolis are both 
antioxidants. 
3.3 Pattern of HIF-1α Protein Expression, FAK, and WNT2 on 
Mammary Tumors in Balb/C Mice 
In this study, expression patterns of genes that play a role in the process of 
angiogenesis (i.e. HIF-1α) and metastasis (Wnt2 and FAK) were observed 
(Figure 3). Our results show that administration of mangostin combined with 
propolis inhibits Wnt2 expression in mammary tumors. This inhibition is also 
expected to have an impact on the tumor metastasis mediated by Wnt2 proteins. 
 
Figure 3 Western blot results of Wnt2 and FAK in tumor tissue of mice treated 
with mangostin and propolis. K- is the negative control group. Dx is the positive 
control group, which was given doxorubicin 14.04 mg/kg bw P is tumor tissue 
from mice that were treated with propolis (0.32 mg/kg bw). M is tumor tissue 
from mice that were treated with mangostin (0.128 mg/kg bw). MP is tumor 
tissue from mice that were treated with propolis (0.32 mg/kg bw) and mangostin 
(0.128 mg /kg bw). 
These results are also supported by Mahmoud, et al. [16], who state that caffeic 
acid phenethyl ester (CAPE), one of the active compounds in propolis, inhibits 
the growth of colorectal cancer cells by decreasing the expression of beta-
catenin in the nucleus and increases the expression of p53, which leads to 
apoptosis. β-catenin is included in the downstream canonical pathway of Wnt2 
[17]. Additionally, Chitchumroonchokchai, et al. [18] have shown that the 
tumor mass and concentration of Bcl-2 and β-catenin in tumors of mice fed with 
an α-mangostin diet were lower than in mice fed with the control diet.  
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Similar with Wnt2, FAK was downregulated in the MP group and the 
expression of FAK in MP group was lower than in groups M and P and was 
closely similar to the Dx group (Figure 3). This inhibition is also expected to 
have an impact on the mechanisms of tumor metastasis mediated by the FAK 
protein. This result is supported by Shih, et al. [19], who have shown that α-
mangostin can inhibit αvβ3 integrin, focal adhesion kinase (FAK), ERK1/2, 
MMP-2 and MMP-9. 
HIF1α expression in group MP as well as in group Dx was totally inhibited, 
while in group M, HIF1α was downregulated. However, in group P the 
expression of the HIF1α protein was greater than in groups K- and M (Figure 
4). It is suspected that the active compounds contained in propolis have a low 
inhibitory effect on HIF1α expression. Hattori, et al. [20] have reported a 
similar result, which indicates that some of the active ingredients in propolis, 
isosakuranetin and beturetol can induce the expression of HIF-1α target genes 
and HIF1α activity in hypoxic conditions. 
M P MP Dx K- 
 
Figure 4 Western blot results of HIF-1α in tumor tissue of mice treated with 
mangostin and propolis. K- is the negative control group. Dx is the positive 
control group, which was given doxorubicin 14.04 mg/kg bw P is tumor tissue 
from mice that were treated with propolis (0.32 mg/kg bw). M is tumor tissue 
from mice that were treated with mangostin (0.128 mg/kg bw). MP is tumor 
tissue from mice that were treated with propolis (0.32 mg/kg bw) and mangostin 
(0.128 mg /kg bw). 
The results show that the combination of propolis and mangostin suppressed the 
expression of Wnt2, FAK and HIF1α. Alpha-mangostin and active compounds 
contained in propolis supposedly interact with proteins that act on a target 
protein, such as p53. Paulino, et al. [21] stated that the active compounds 
contained in propolis, such as Artepillin C or CAPE, can increase the 
expression of p53, which plays a role in the apoptosis process. Watanapokasin, 
et al. [22] have shown that expression of p53 protein increased in the COLO205 
cell line after treatment with 20 μg/ml of mangostin for 3 hours. Chinese 
propolis extract caused an increase of p53 mRNA levels in HCT116 cell lines 
[23]. Therefore, both propolis and mangostin may cause p53 to be retained in 
the cell and to be bound to Mdm2 leading to HIF1α degradation. Kaur, et al. 
[24] mention that p53 modulates Mdm2 by adding ubiquitin to HIF1α proteins, 
HIF1α (125kDa) 
Actin (42 kDa) 
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which affect HIF1α degradation. On the other hand, retention of p53 in cancer 
cells may have suppressed FAK in the MP group in this research. 
Golubovskaya, et al. [25] have shown that FAK regulates p53 protein in cancer 
cells. 
The inhibition mechanism of propolis and mangostin on Wnt expression is still 
unclear, but it is assumed that mangostin and propolis can suppress the 
expression of Wnt in Balb/C mice, which subsequently leads to the decline of β-
catenin as a result of β-catenin degradation. The degradation of β-catenin can be 
due to increased expression of p53 in cancer cells of the mice in the MP group. 
Sadot, et al. [26] state that p53 wild-type can decrease β-catenin expression in 
human and mice cells. 
4 Conclusions 
Administration of a combination of propolis and mangotin as an alternative 
treatment as part of cancer therapy is a safe therapy in view of the insignificant 
effect of both treatments on the body weight of the Balb/C mice. The 
combination of mangostin and propolis is able to inhibit cancer development 
and has potential anti-angiogenic and anti-metastatic activity due to a 
downregulated expression of Wnt2, FAK, and HIF1α in the cancer tissue. 
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